Stockreport

Zevra Reports Fourth Quarter and Full Year 2025 Financial Results

Zevra Therapeutics, Inc.  (ZVRA) 
PDF Q4 net revenue of $34.1 million, representing 31% growth quarter-over-quarter FY 2025 net revenue of $106.5 million, driven by growth in MIPLYFFA® net revenue to $87.4 [Read more]